Table 1.
HIV-1 Tat protein variant lengths, clades, vendors and functional domains
| Peptide Length | Clade | Vendor | Functional Domains |
|---|---|---|---|
| 1–86 | B | Diatheva, Italy | 1st exon + 14 amino acids |
| 1–86[Cys22] | -- | Diatheva, Italy | 1st exon + 14 amino acids; mutation in the cysteine rich domain (Cys22) |
| 1–101 | B | Immunodiagnostic, MA USA | First and second exon; Cysteine rich domain intact |
| 1–101 | C | Prospec, Israel | First and second exon with a mutation in the cysteine rich domain (Cys31) |
| 1–72δ31–61 | -- | U. of Kentucky, USA | 1st exon with a portion of the cysteine rich, the core, the arginine rich, and 4 residues of the glutamine rich domain deleted. |
| 1–72 | B | U. of Kentucky, USA | First exon; Cysteine rich domain intact |
| 47–57 | -- | Anaspec, CA USA | End of the core domain and the arginine rich domain; No cysteine domain present |